WPC
XENE icon

Wedmont Private Capital’s Xenon Pharmaceuticals XENE Stock Holding History

Wedmont Private Capital’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$408K Buy
+11,275
New +$670K 0.01% 656

Other funds holding XENE

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Wedmont Private Capital's XENE Position: Q3 2026 in Review

Wedmont Private Capital opened a new position in Xenon Pharmaceuticals (XENE) in Q3 2026: 11,275 shares worth $408K. The stake represents 0.01% of the portfolio and ranks #656 among its holdings.

5 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • Wedmont Private Capital held 11,275 shares of Xenon Pharmaceuticals worth $408K as of Q3 2026.
  • Xenon Pharmaceuticals was a new Wedmont Private Capital position in Q3 2026.
  • Xenon Pharmaceuticals made up 0.01% of Wedmont Private Capital's portfolio in Q3 2026, its #656 holding.
  • 5 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on Wedmont Private Capital's 13F filing for Q3 2026, filed 9 Oct 2026.